JD Health International Inc.
JD Health International Inc. Fundamental Analysis
JD Health International Inc. (JDHIF) shows moderate financial fundamentals with a PE ratio of 25.54, profit margin of 7.32%, and ROE of 9.03%. The company generates $72.6B in annual revenue with strong year-over-year growth of 23.01%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 67.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze JDHIF's fundamental strength across five key dimensions:
Efficiency Score
WeakJDHIF struggles to generate sufficient returns from assets.
Valuation Score
ModerateJDHIF shows balanced valuation metrics.
Growth Score
ExcellentJDHIF delivers strong and consistent growth momentum.
Financial Health Score
ExcellentJDHIF maintains a strong and stable balance sheet.
Profitability Score
WeakJDHIF struggles to sustain strong margins.
Key Financial Metrics
Is JDHIF Expensive or Cheap?
P/E Ratio
JDHIF trades at 25.54 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, JDHIF's PEG of 0.35 indicates potential undervaluation.
Price to Book
The market values JD Health International Inc. at 2.27 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 40.40 times EBITDA. This signals the market has high growth expectations.
How Well Does JDHIF Make Money?
Net Profit Margin
For every $100 in sales, JD Health International Inc. keeps $7.32 as profit after all expenses.
Operating Margin
Core operations generate 5.30 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.03 in profit for every $100 of shareholder equity.
ROA
JD Health International Inc. generates $6.53 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
JD Health International Inc. produces operating cash flow of $10.28B, showing steady but balanced cash generation.
Free Cash Flow
JD Health International Inc. produces free cash flow of $6.19B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.93 in free cash annually.
FCF Yield
JDHIF converts 4.57% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
25.54
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.35
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.27
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.87
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.01
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.72
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.09
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How JDHIF Stacks Against Its Sector Peers
| Metric | JDHIF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 25.54 | 27.91 | Neutral |
| ROE | 9.03% | 687.00% | Weak |
| Net Margin | 7.32% | -45285.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 0.33 | Strong (Low Leverage) |
| Current Ratio | 2.72 | 2795.76 | Strong Liquidity |
| ROA | 6.53% | -13557.00% (disorted) | Weak |
JDHIF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews JD Health International Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
157.68%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
121.21%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
87.50%
Industry Style: Defensive, Growth, Innovation
High Growth